about
Short communication: kidney dysfunction among HIV-infected children in Latin America and the CaribbeanSyphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study.Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life.Knowledge, perceived stigma, and care-seeking experiences for sexually transmitted infections: a qualitative study from the perspective of public clinic attendees in Rio de Janeiro, Brazil.Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV TransmissionShort communication: neutralizing antibodies in HIV-1-infected Brazilian individuals.Three postpartum antiretroviral regimens to prevent intrapartum HIV infectionChlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients: week 48 results of the ARIEL trial.A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.Evaluation of HBsAg and anti-HBc assays in saliva and dried blood spot samples according HIV status.Virologic outcomes in early antiretroviral treatment: HPTN 052.Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status.Nevirapine concentrations in newborns receiving an extended prophylactic regimen.HIV Antiretroviral Resistance and Transmission in Mother–Infant Pairs Enrolled in a Large Perinatal Study.Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.Congenital CMV and HIV Perinatal Transmission.Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV InfectionHigh emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil
P50
Q34267297-A5A90F43-2BC4-4A34-9034-2DA252F6EF09Q35156725-79446701-E34A-4018-BD11-3ACEA0D9B478Q35171059-80F80072-1E11-4453-96A5-38667C9A4FE4Q35634104-F4F0CD2B-886F-4279-8EAE-232CEBED155CQ36063383-305E7826-ED4E-43D5-9D69-AD31AC45E0E9Q36638489-09F8435A-604E-4AB9-9089-EE6C293A49A7Q36662110-CBE7476B-566D-4722-A9DE-6BFB00C6F6B0Q37836433-0D66ECC3-F61C-477E-B02B-EB6A79B213B8Q38365430-2C5BDD06-4125-4E63-9FDF-B1F4A1C9AF2BQ38657651-27EFCB7C-0FA0-45E9-BC65-BC1963139265Q40200650-3FDF46AB-33F9-456A-AF85-96CE082205EAQ40254515-51378274-FC0C-4F05-9D98-1EE89898C939Q40261944-FA1F5B40-3A6B-4AC6-9D2F-D9ADDC19B0E0Q40343820-131A1330-5AAE-44ED-BB91-A1BB685A7832Q43708324-3BFE2C85-2DC3-4ABD-B515-F6C38E14FC57Q47127849-D48E224E-DBC9-4307-B1F2-89550DB287DAQ48303065-F8475060-2B5C-4D8F-AB06-0AB1EF4B2DD3Q49617530-B4A18CBB-A45D-4828-9E7B-201E0AAC1FA9Q54214490-9FBCD244-81F3-4E71-9F1D-4837968B8FD9Q54257908-C4C817FC-F96E-4760-9057-9D242B4D6252Q57953574-5700B72D-729C-4AD7-9A08-8C3B4F6414A8Q59249265-6A08F5C1-F119-42F7-B3B7-87CB5BEB7055
P50
description
researcher ORCID ID = 0000-0003-0521-8597
@en
wetenschapper
@nl
name
Jose Henrique Pilotto
@ast
Jose Henrique Pilotto
@en
Jose Henrique Pilotto
@es
Jose Henrique Pilotto
@nl
type
label
Jose Henrique Pilotto
@ast
Jose Henrique Pilotto
@en
Jose Henrique Pilotto
@es
Jose Henrique Pilotto
@nl
prefLabel
Jose Henrique Pilotto
@ast
Jose Henrique Pilotto
@en
Jose Henrique Pilotto
@es
Jose Henrique Pilotto
@nl
P21
P31
P496
0000-0003-0521-8597